Status:
COMPLETED
Recombinant Human Erythropoietin Compared to Autologous Pre-Donation Prior to Scoliosis Surgery in Children.
Lead Sponsor:
University of British Columbia
Conditions:
Scoliosis
Eligibility:
All Genders
12-18 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to establish whether rHuEpo is as effective as PAD in increasing red cell mass prior to surgery. Other benefits of the PAD program and preoperative administration of rHuEp...
Detailed Description
Background The pre-operative autologous donation (PAD) program was established at British Columbia's Children's Hospital in 1988 to decrease the need for homologous blood transfusion. It could allevia...
Eligibility Criteria
Inclusion
- Scoliosis repair
Exclusion
- \-
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00323752
Start Date
October 1 2004
End Date
December 1 2007
Last Update
September 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
British Columbia Children's Hospital
Vancouver, British Columbia, Canada